Sarah Rieck

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

High Fat Diet Induced

Polycyclic Aromatic Hydrocarbons

Pulmonary Hypertension

Endothelial Cells

Top Venues

EMBO molecular medicine

Cardiovascular research

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Seidinger, Richard Roberts, Yan Bai, Marion Müller, Eva Pfeil, Michaela Matthey, Sarah Rieck, Judith Alenfelder, Gabriele M König, Alexander Pfeifer, Evi Kostenis, Anna Klinke, Bernd K Fleischmann, Daniela Wenzel
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension. EMBO molecular medicine 16 (8) (2024)
Alexander Seidinger, Richard Roberts, Yan Bai, Marion Müller, Eva Pfeil, Michaela Matthey, Sarah Rieck, Judith Alenfelder, Gabriele M König, Alexander Pfeifer, Evi Kostenis, Anna Klinke, Bernd K Fleischmann, Daniela Wenzel
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension. EMBO molecular medicine 16 (8) (2024)
Alexander Seidinger, Richard Roberts, Yan Bai, Marion Müller, Eva Pfeil, Michaela Matthey, Sarah Rieck, Judith Alenfelder, Gabriele M König, Alexander Pfeifer, Evi Kostenis, Anna Klinke, Bernd K Fleischmann, Daniela Wenzel
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension. EMBO molecular medicine 16 (8) (2024)
Sarah Rieck, Kritika Sharma, Carlotta Altringer, Michael Hesse, Christos Triantafyllou, Yanhui Zhang, Volker Busskamp, Bernd K Fleischmann
Forward programming of hiPSCs via the transcription factor ETV2: rapid, reproducible, and cost-effective generation of highly enriched, functional endothelial cells. Cardiovascular research (2024)
Alexander Seidinger, Richard Roberts, Yan Bai, Marion Müller, Eva Pfeil, Michaela Matthey, Sarah Rieck, Judith Alenfelder, Gabriele M König, Alexander Pfeifer, Evi Kostenis, Anna Klinke, Bernd K Fleischmann, Daniela Wenzel
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension. EMBO molecular medicine (2024)